Talen Energy Corp V.TLN

Primary Symbol: TLN

Talen Energy Corporation owns and operates power infrastructure in the United States. The Company produces and sells electricity, capacity, and ancillary services in wholesale power markets in the United States, primarily in PJM and WECC, with its generation fleet principally located in the Mid-Atlantic region of the United States and Montana. The majority of its generation is produced at its zero-carbon nuclear and lower-carbon gas-fired facilities. Its generation capacity is 10,665 megawatts (MW). Its segments include PJM and Other. The PJM segment is engaged in electricity generation, marketing activities, commodity risk and fuel management within the PJM RTO or ISO markets and comprises Susquehanna and Talen’s natural gas and coal generation facilities. Its Other segment includes the operating and marketing activities of Talen Montana’s proportionate share of the Colstrip Units in the WECC market, the operating activities of Nautilus, and other development activities.

NDAQ:TLN - Post by User

Talen Energy Corp

Bullboard Posts

Post by everswannon Jul 30, 2009 1:32pm

284 Views

Post# 16179170

TLN-4601 gets official name

Another sign that 4601 is gearing for successful efficacy results is the fact that it has now a name "Diazepinomicin"

https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summary_pr?p_JournalId=2&p_RefId=1370797&p_IsPs=N

Biotech don't give name to early testing compound. It's when a compound is nearing marketing stage that it does get one.

By the way, for GBM drug canditate marketing day = End of PIIb.
PIIb is a confirmatory trial.
We get maximum upside at PIIa, ie the pivotal trial.

I guess I know more about Biotech than it looks like....

4601 or should I say Diazepinomicin is now a "drug of the future" according to Thompson FInancial.

Pepmoron
Take this info and stick it up your ____

Also get ready to jump! Time to do it is soon!

Bullboard Posts

Level up your trading with BMO InvestorLine’s enhanced features